SAGE sagerx.com Sof moliyaviy natija

Sage Therapeutics Inc. (SAGE) kompaniyasining rasmiy ramzlari

Ilmiy xodimlarning sodiqligi barqaror poydevor yaratadi, biroq Sage Therapeutics, Inc. (SAGE) kompaniyasining uzoq muddatli muvaffaqiyati Zurzuvae dori vositasining tijoratlashtirilishi va depressiyaga qarshi kurashga bog'liq. GURU.Markets interfeysi ushbu grafikni namoyish etadi, unda kompaniyaning moliyaviy foydasi -0.30 metrik qiymati bilan qayd etilgan. Ushbu tendentsiya hali to'yinish nuqtasiga yetmagan segmentda innovatsion neyropreparatlarga bo'lgan talabning ortishi bilan tasdiqlanadi.

Sage Therapeutics, Inc (SAGE) Sof foyda: 04.07.2022 - 16.08.2025 davri uchun

Sage Therapeutics (SAGE) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Sage Therapeutics Inc|SAGE - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Sage Therapeutics Inc|SAGE - Korxona qiymati
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
Bitta aksiya hisobiga balans qiymati Sage Therapeutics|SAGE - Balans kapitallashuvi|Bozor qiymatining xususiy kapitalga nisbati sagerx.com|SAGE - Kompaniyaning umumiy aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Sage Therapeutics, Inc.|SAGE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Sage Therapeutics Inc.|SAGE - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Sage Therapeutics Inc|SAGE - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari Sage Therapeutics|Shoshilinch likvidlik sagerx.com
- foyda va bozor multiplikatorlari tafsilotlari:
SAGE - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Sage Therapeutics Inc - SAGE
Sage Therapeutics Inc. brend mahsuloti

Uzoq muddatli investitsiyalar davomida xatarlarni minimallashtirish uchun kompaniyaning sof foyda dinamikasini tahlil qilish juda muhimdir, chunki u kunlik bozor muvozanati nuqtalari orqali tebranishlarni filtrlaydi va qiymatning haqiqiy drayverlarini ochib beradi. Sage Therapeutics, Inc. (SAGE) uchun ushbu ko'rsatkich Barry Green strategiyasining ulkan R&D xarajatlari va antidepressantlar tijoratlashtirilishini muvozanatga keltirishdagi samaradorligini aks ettirib, biznesning fundamental barqarorligini tasdiqlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|regencellbioscience.com (RGC) - Sof moliyaviy natija|Sof foyda AXSM|Sof foyda ACADIA Pharma (ACAD)|Sof foyda XENE (Xenon Pharmaceuticals Inc)|Yillik sof foyda Viking Therapeutics Corp|Supernus Pharmaceuticals - Sof foyda|Kompaniyaning sof daromadi catalystpharma.com|DNLI (Denali Therapeutics Inc.) - Sof daromad|Harmony Biosciences Inc - Yakuniy foyda|Sof daromad BHVN|AMLX (Amylyx Corp) - Soliqlar to‘langandan keyingi foyda|Sof foyda TRVI|PRAX (praxismedicines.com) - Yakuniy foyda|Sof foyda AVXL (Anavex Life Sciences Corp.)|CeriBell Inc (CBLL) - Kompaniyaning sof daromadi|PRTA - Kompaniyaning sof foydasi|Yakuniy foyda ALEC (Alector, Inc.)|ANNX: Sof foyda|Omeros (OMER) - Sof foyda|Kompaniyaning sof foydasi Neurogene|AC Immune S.A. - Soliqdan keyingi foyda|Sof foyda VYGR|NMRA - Kompaniyaning sof daromadi|Scilex Holding Company - Sof daromad|Sof foyda tevogen.com TVGN|ACOG: Sof daromad|cogrx.com - Soliqlar to‘langandan keyingi foyda|IKT: Sof foyda|SAVA - Sof moliyaviy natija|ASRT (Assertio Holdings) - Sof foyda|Sof daromad Coya (COYA)|Kompaniyaning sof foydasi Vistagen Therapeutics (VTGN)|Sof moliyaviy natija ovidrx.com|Acumen Pharma - Sof daromad|Yakuniy foyda CRVO|Alterity Therapeutics Ltd - Sof foyda|Sof moliyaviy natija Clene Inc. CLNN|pepgen.com (PEPG) - Kompaniyaning sof foydasi|Kompaniya foydasi JUNS|RLMD (Relmada) - Sof foyda|Sof daromad Annovis Bio Corporation (ANVS)|Sof daromad GRCE (Grace Therapeutics, Inc.)|Sof moliyaviy natija fireflyneuro.com|Kompaniyaning sof foydasi Klotho Neurosciences KLTO|Sof moliyaviy natija NeuroSense Therapeutics Ltd (NRSN)|Reviva Pharmaceuticals Holdings - Sof foyda|MTVA - Sof foyda|NRXS: Sof foyda|Yillik sof foyda Helius Medical Technologies HSDT|PASG (Passage Bio Inc.) - Sof foyda|Kompaniyaning sof daromadi Neuphoria NEUP|Kompaniyaning sof foydasi Minerva Neurosciences Corp (NERV)|Athira Pharma Corp - Kompaniya foydasi|Sof foyda ADXN (Addex Therapeutics)|Alzamend Neuro Inc. (ALZN) - Kompaniyaning sof daromadi|CYCN: Sof daromad|PTIX - Sof foyda|pasitheaclinics.com (KTTA) - Kompaniyaning sof foydasi|Cortigent - Yakuniy foyda|Kompaniyaning sof foydasi Avenue Therapeutics|Kompaniyaning sof daromadi brainstorm-cell.com BCLI|Kompaniyaning sof foydasi Cara Therapeutics (CARA)|Sof moliyaviy natija Chromocell Therapeutics Corp|Sof foyda ELYM (Eliem Therapeutics Inc.)|Sof foyda Intra-Cellular Therapies Inc. ITCI|Longboard Pharmaceuticals - Sof foyda|Yillik sof foyda marinuspharma.com (MRNS)|NKGN: Sof foyda|Kompaniyaning sof daromadi NeuroBo Pharmaceuticals Inc (NRBO)|Sof daromad SNPX|TRVN: Yakuniy foyda|Sof daromad VIGL (Vigil Neuroscience)|Soliqlar to‘langandan keyingi foyda WENA|Sof foyda CERE (Cerevel Therapeutics, Inc.)